Miriam Marquis
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.
Journal: Biomarker research
Published: May 15, 2025
Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting.
Journal: Applied health economics and health policy
Published: August 09, 2019
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.
Journal: Blood cancer journal
Published: March 29, 2018
Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin.
Journal: Leukemia
Published: October 22, 2017
The atypical MAPK ERK3 controls positive selection of thymocytes.
Journal: Immunology
Published: October 31, 2014
The catalytic activity of the mitogen-activated protein kinase extracellular signal-regulated kinase 3 is required to sustain CD4+ CD8+ thymocyte survival.
Journal: Molecular and cellular biology
Published: July 09, 2014
The non-classical MAP kinase ERK3 controls T cell activation.
Journal: PloS one
Published: September 19, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026